NCT00677872View on ClinicalTrials.gov

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Conditions
COPDPulmonary Hypertension
Interventions
DRUG

PRX-08066

Trial Locations (1)

02114

Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston

Sponsors
All Listed Sponsors
lead

Epix Pharmaceuticals, Inc.

INDUSTRY